Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.

[1]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[2]  Peter A. Ward,et al.  The complement system , 1981, Cell and Tissue Research.

[3]  A. Bellatorre,et al.  Plasma biomarkers of acute attacks in patients with angioedema due to C1‐inhibitor deficiency , 2009, Allergy.

[4]  H. Joller-jemelka,et al.  Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. , 2008, Journal of immunological methods.

[5]  D. Rabczenko,et al.  Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults , 2008, Archivum Immunologiae et Therapiae Experimentalis.

[6]  William H. Yang,et al.  Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  M. Tarzi,et al.  An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio‐oedema , 2007, Clinical and experimental immunology.

[8]  M. Gompels,et al.  Laboratory testing for C1 inhibitor deficiency: a comparison of two approaches to C1 inhibitor function , 2007, Annals of clinical biochemistry.

[9]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[10]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[11]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[12]  A. Tordai,et al.  Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema , 2003, Human mutation.

[13]  M. Gompels,et al.  Misdiagnosis of hereditary angio‐oedema type 1 and type 2 , 2003, The British journal of dermatology.

[14]  M. Gompels,et al.  A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. , 2002, Journal of clinical pathology.

[15]  P. Mannucci,et al.  Activation of the coagulation cascade in C1-inhibitor deficiencies. , 1997, Blood.

[16]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[17]  A. Agostoni.  Inherited C1 inhibitor deficiency. , 1989, Complement and inflammation.

[18]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[19]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[20]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[21]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.